siRNA, Anti-Human ACTA1, LNA(CAT#: SIRGT04041WQ-LNA)

The product SIRGT04041WQ-LNA is a type of small interfering RNA (siRNA) that targets ACTA1 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTA1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001100.3
Alternative Names ACTA; ASMA; CFTD; CFTD1; CFTDM; MPFD; NEM1; NEM2; NEM3; SHPM
Related Diseases Nemaline myopathy, Congenital myopathy
Purification HPLC
Target Gene
Gene ID 58
Uniprot ID P68133

Related Products